Medicalgorithmics S.A.

Registration Form • Nov 18, 2025

Report Content Informationon the registration of amendments to the Company's Articles ofAssociation

CurrentReport No.: 37/2025

Date:18.11.2025 r.

Legalbasis: Art. 56 sec. 1 point 2 of the Act on Public Offering - currentand periodic information

TheManagement Board of Medicalgorithmics S.A. with its registered office inWarsaw (the "Company") hereby announces that today theCompany received a decision of the District Court for the Capital Cityof Warsaw in Warsaw, 12th Commercial Division of the National CourtRegister, dated November 18, 2025, regarding the entry of an amendmentto the Company's Articles of Association made in connection with theadoption of Resolution No. 5/11/2025 and Resolution No. 6/11/2025 by theExtraordinary General Meeting of Medicalgorithmics S.A. with itsregistered office in Warsaw on November 3, 2025. Resolution No.5/11/2025 and Resolution No. 6/11/2025, of which the Company informed inits current report No. 36/2025 of November 3, 2025 ("Resolutions").

Inconnection with the adoption of the above Resolutions, an amendment wasmade to § 5a of the Company's Articles of Association in such a waythat: (i) paragraphs 1-3 (repealed) were reworded, and (ii) newparagraphs 4-6 were added. Following the above amendments, § 5a wasreworded as follows:

"§5a

1.Repealed.

2.Repealed

3.Repealed.

4.Thenominal value of the conditional increase in the Company's share capitalcreated for the purposes of implementing the Incentive Program adoptedon the basis of Resolution No. 6/11/2025 of November 3, 2025 of theExtraordinary General Meeting of the Company on the introduction of theIncentive Program for the financial years 2025 - 2027, together with anysubsequent amendments to this resolution (the "ProgramResolution"), shall not exceed PLN 29,858.40 (twenty-nine thousandeight hundred and fifty-eight zlotys and forty groszy) and shall bedivided into:

a)nomore than 99,528 (ninety-nine thousand five hundred and twenty-eight)series M ordinary bearer shares with a nominal value of PLN 0.10 (tengroszy) each ("Series M Shares");

b)nomore than 99,528 (ninety-nine thousand five hundred and twenty-eight)series N ordinary bearer shares with a nominal value of PLN 0.10 (tengroszy) each ("Series N Shares");

c)nomore than 99,528 (ninety-nine thousand five hundred and twenty-eight)series O ordinary bearer shares with a nominal value of PLN 0.10 (tengroszy) each ("Series O Shares").

5.Thepurpose of the conditional increase in share capital is:

a)grantingthe right to acquire Series M Shares to holders of Series A SubscriptionWarrants issued by the Company pursuant to the Program Resolution,

b)grantingthe right to acquire Series N Shares to holders of Series B SubscriptionWarrants issued by the Company pursuant to the Program Resolution,

c)grantingthe right to acquire Series O Shares to holders of Series C SubscriptionWarrants issued by the Company pursuant to the Program Resolution.

6.Theright to acquire Series M Shares, Series N Shares and Series O Sharesmay be exercised until 31 December 2030."

Attachedto this current report, the Company provides the consolidated text ofthe Company's Articles of Association, taking into account the amendmentmade pursuant to the Resolutions.